![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1433392
¼¼°è ÇÏÁö Àåºñ ½ÃÀå(2023-2030³â)Global Lower Extremity Devices Market 2023-2030 |
¼¼°èÀÇ ÇÏÁö Àåºñ ½ÃÀåÀº ¿¹Ãø±â°£(2023-2030³â)¿¡ CAGR 5.0%·Î »ó´çÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¹è°æ¿¡´Â ºñħ½ÀÀûÀÎ Ä¡·á¿Í ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ȯÀÚ¿Í ÀÇ»ç´Â ºñħ½ÀÀûÀ̰ųª ³·Àº ħ½ÀÀû Ä¡·á ¼Ö·ç¼ÇÀ» ã°í ÀÖ½À´Ï´Ù. VRÀ» ÀÌ¿ëÇÑ Ä¡·á´Â ÀÌ·¯ÇÑ µ¿Çâ¿¡ ºÎÇÕÇϸç, ºñħ½ÀÀûÀÎ ÀçȰ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â ÇÏÁö ÀåºñÀÇ Ã¤¿ëÀ» ÃËÁøÇÒ °¡´É¼ºÀ» Áö´Ï°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Penumbra»ç´Â 2022³â 11¿ù, Àü½Å VR º£À̽ºÀÇ »õ·Î¿î REAL y-Series ÀçȰ Ç÷§ÆûÀ» ¹ßÇ¥Çß½À´Ï´Ù. REAL y-Series¿¡´Â »ó¹Ý½Å°ú ÇϹݽм¾¼°¡ žÀçµÇ¾î ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ÀÇ»ç´Â »ç¿ëÀÚ Á¤ÀÇµÈ ¿îµ¿°ú Ȱµ¿À» ÅëÇØ ½Ç½Ã°£À¸·Î Àü½ÅÀÇ ¿òÁ÷ÀÓ°ú °³¼±À» ÃßÀûÇÒ ¼ö ÀÖ½À´Ï´Ù. REAL y-Series Á¦Ç°±ºÀº ¹°¸®Ä¡·á³ª ÀÛ¾÷ Ä¡·á¸¦ ¹Þ´Â ȯÀÚÀÇ ½ÅüÀû, ÀÎÁöÀû, Á¤½ÅÀû °Ç° ÁõÁøÀ» Áö¿øÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀûÀÎ Á¦Ç°ÀÇ Ãâ½Ã´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í °ÈÇϰí ÀÖ½À´Ï´Ù.
Á¦Ç°º°·Î´Â ¹ß°ú ¹ß°üÀý ±â±¸ ÇÏÀ§ ºÎ¹®ÀÌ ¼¼°è ÇÏÁöÀ屸 ½ÃÀå¿¡¼ Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ß Á¡À¯À²ÀÌ ³ô´Ù´Â °ÍÀº ½Å°æÁúȯ Ä¡·á¿¡¼ ÀÌ·¯ÇÑ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ³úÁ¹Áß, ³ú¼º ¸¶ºñ, ô¼ö ¼Õ»óÀº ¼¼°èÀûÀ¸·Î Áõ°¡ÇÏ´Â °æÇâÀÌ ÀÖ½À´Ï´Ù. AFO¿Í °°Àº Àåºñ ¿ä±¸´Â ÀÌ·¯ÇÑ Áõ»ó ÀçȰ°ú °ü¸®¿¡ ´ëÀÀÇÏ¿© È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 2021³â 8¿ù ±¹¸³Á¤ºÎ¿¬±¸¼Ò(Á¤ºÎ)¿¡ µû¸£¸é ¹ß°üÀýÀ屸(AFO)´Â ³úÁ¹Áß, ³ú¼º¸¶ºñ, ô¼ö¼Õ»ó, ¸»ÃÊ½Å°æ ¼Õ»ó µî Àå¾Ö·Î ÀÎÇØ ¹ß°üÀý ¹è±¼±Ù ¶Ç´Â ¹ß¹Ù´Ú ±¼±Ù±Ù·ÂÀÌ ÀúÇÏµÈ È¯ÀÚ ÀϹÝÀûÀÎ ÀåºñÀÔ´Ï´Ù. ¹ß °üÀý°ú ¹ß Á¤·ÄÀ» À¯ÁöÇÏ°í º¯ÇüÀ» ¿¹¹æÇÏ¸ç ¾ÈÁ¤µÈ ÀÚ¼¼¸¦ À¯ÁöÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. º» Á¶»ç¿¡¼´Â ±âÁ¸ AFO¸¦ °³¼³Çϰí, ÃÖ±Ù °³¹ß AFO¸¦ ¼Ò°³Çϰí, Àå´ÜÁ¡À» ºñ±³Çϰí, ÀÓ»ó¿¡¼ AFO¸¦ ó¹æÇϱâ À§ÇÑ ±âÃÊ µ¥ÀÌÅ͸¦ Á¦°øÇÕ´Ï´Ù.
¼¼°èÀÇ ´Ù¸® Àåºñ ½ÃÀåÀº ºÏ¹Ì(¹Ì±¹, ij³ª´Ù), À¯·´(¿µ±¹, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, µ¶ÀÏ, ÇÁ¶û½º ¹× ±âŸ À¯·´), ¾Æ½Ã¾ÆÅÂÆò¾ç(Àεµ, Áß±¹, ÀϺ», Çѱ¹, ±âŸ ¾Æ½Ã¾Æ Áö¿ª), ¼¼°è ±âŸ Áö¿ª(Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, ¶óƾ¾Æ¸Þ¸®Ä«)À» Æ÷ÇÔÇÑ Áö¿ªº°·Î ´õ¿í ¼¼ºÐȵǾî ÀÖ½À´Ï´Ù. ±× Áß¿¡¼µµ ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ³ëÀÎ Áõ°¡, ÀÇ·á ÀÎÇÁ¶ó °È, ÅõÀÚ ÇÁ·ÎÁ§Æ® Áõ°¡´Â Áö¿ª ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.
¸ðµç Áö¿ª¿¡¼ ºÏ¹Ì´Â ¿¹Ãø ±â°£ µ¿¾È »ó´çÈ÷ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ Áö¿ª ¼ºÀåÀº Áö¿ª Àüü¿¡¼ °³º°È º¸Ã¶ ¼Ö·ç¼ÇÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. °³ÀÎÀÇ ÇÊ¿ä¿Í ¶óÀÌÇÁ ½ºÅ¸ÀÏÀ» ÃæÁ·½Ã۱â À§ÇØ ÀÇÁö Àåºñ¸¦ °³º°ÈÇÏ¸é »ç¿ëÀ» ÃËÁøÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. Ä¿½ºÅ͸¶ÀÌ¡°ú ÇÇÆÃÀÇ Çâ»óÀ¸·Î ´õ ¸¹Àº Àý´Ü ȯÀÚµéÀÌ Á¤±âÀûÀ¸·Î ÀÇÁö¸¦ »ç¿ëÇÏ°Ô µË´Ï´Ù. ±¹¸³Á¤ºÎ¿¬±¸¼Ò(GOV)¿¡ µû¸£¸é 2023³â 7¿ù ÇöÀç »çÁö Àý´ÜÀº Á¤Çü¿Ü°ú Áø·á¿¡ ÀÖ¾î¼ ÀϹÝÀûÀÎ ¹®Á¦À̸ç, ¹Ì±¹¿¡¼´Â 2005³â ½ÃÁ¡¿¡¼ 200¸¸¸í °¡±îÀÌ »çÁö¸¦ ÀÒÀº »óÅ·Π»ýȰÇϰí ÀÖ´Ù ÇÕ´Ï´Ù. ´Ù¸® Àý´Üµµ ÀϹÝÀûÀÌ¸ç ¿¬°£ 11¸¸ ¸íÀÌ ´ë¼ö¼úÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ±× 70.0%´Â Áúº´À¸·Î ÀÎÇÑ °ÍÀÌ¸ç ³ª¸ÓÁö´Â ¿Ü»ó, ¼±Ãµ¼º ÀÌ»ó, Á¾¾ç ¶§¹®ÀÔ´Ï´Ù. Àý´ÜÀÚ Áß ÀÏ»óº¸ÇàÀÇ Àý¹Ý ÀÌ»óÀ» ÀÇÁ·À¸·Î ÇÏ´Â °ÍÀº ºÒ°ú 5.0%ÀÔ´Ï´Ù.
¿¹¸¦ µé¾î, 2022³â 2¿ù, DePuySynthes´Â Å׳׽à ÁÖ¿¡ º»»ç¸¦ µÐ ¹ß°ú ¹ß¸ñ ȸ»çÀÎ CrossRoads Extremity Systems¸¦ ÀμöÇß½À´Ï´Ù. CrossRoads Extremity Systems´Â ´Ù¸®ÀÇ ÀûÀÀÁõ¿¡ Çã°¡µÈ ÀýÂ÷¿¡ Æ¯ÈµÈ ¹«±Õ ÆÑ ÀÓÇöõÆ® ¹× ±â±¸ ½Ã½ºÅÛÀ» ±¤¹üÀ§ÇÏ°Ô Á¦°øÇÕ´Ï´Ù. ÇÁ¶óÀ̺ø ÁÖ½Ä È¸»çÀÎ HealthpointCapitalÀº ¹ß°ú ¹ß¸ñÀÇ ¼ºÀå ¸®´õÀÎ CrossRoads¿¡ ÅõÀÚÇÏ¿© »ç³»¿ÜÀÇ Çõ½ÅÀ» ÅëÇØ Á¤Çü¿Ü°ú, ¹ßº´, ÀÇ·á±â¼úÀÇ Áøº¸¿¡ ´ëÇÑ µ¥Ç» ½Å¼¼½ºÀÇ Çå½ÅÀ» ½ÇÁõÇß½À´Ï´Ù.
Global Lower Extremity Devices Market Size, Share &Trends Analysis Report by Product (Knee Orthotics, Foot and Ankle Orthotics, and Hip Orthotics), by Application (Trauma and Fractures, Podiatry and Foot Care, and Others) and by End-User (Hospitals, and Specialty Centre), Forecast Period (2023-2030)
The global lower extremity devices market is anticipated to grow at a considerable CAGR of 5.0% during the forecast period (2023-2030). The market's growth is attributed to the rising demand for non-invasive treatments and surgeries. Patients and doctors are seeking for non-invasive or minimally invasive therapy solutions. VR-based therapy is consistent with this trend, and it has the potential to drive the adoption of lower extremity devices that provide non-invasive rehabilitation solutions. For instance, in November 2022, Penumbra introduced new full-body VR-based REAL y-Series rehab platform. Upper and lower body sensors are included with the REAL y-Series device. It enables physicians to track full-body movement and improvement in real time via customized exercises and activities. The REAL y-Series product line is designed to help patients undergoing physical or occupational therapy enhance their physical, cognitive, and mental well-being. Such innovative product launches are further aiding to the market growth.
The global lower extremity devices market is segmented on the product, application, and end-user. Based on the product, the market is sub-segmented into knee orthotics, foot and ankle orthotics, and hip orthotics. Based on the application, the market is sub-segmented into trauma and fractures, podiatry and foot care, and others. Furthermore, on the basis of end-user, the market is sub-segmented into hospitals, and specialty center. The trauma and fractures subcategory is expected to capture a significant portion of the market share within the application segment. The growth can be attributed to an increase in road accidents that leads to more fractures and injuries that creates demand for different surgeries for their treatment.
Among the product, the foot and ankle orthotics sub-segment holds a considerable share of the global lower extremity devices market. The high share of the segment is attributed to the increased demand for these devices in treatment of neurological disorders. Stroke, cerebral palsy, and spinal cord injuries are on the rise globally. The need for orthotic devices such as AFOs is expected to expand in response to these conditions' rehabilitation and management. According to the National institute of Government (gov.) in August 2021, ankle-foot orthosis (AFO) is a common orthosis for patients with ankle dorsiflexor or plantarflexor muscle weakness owing to disorders such as, stroke, cerebral palsy, spinal cord injury, and peripheral nerve injury. It helps maintain ankle and foot alignment, prevents deformities, and maintains a stable posture. This study reviews conventional AFOs and introduces recently developed ones, comparing advantages and disadvantages and providing basic data for prescribing AFOs in clinical practice.
The global lower extremity devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to exhibit fastest growth during the forecast period. The rise in elderly individuals, enhancement of healthcare infrastructure and increase in investments projects in the region are key contributors to the regional market growth.
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the personalized prosthetic solutions across the region. Individualizing prosthetic devices to satisfy individual needs and lifestyles helps to boost utilization. Customization and improved fitting devices can encourage more amputees to utilize their prostheses on a regular basis. According to the National Institute of Government (gov.), in July 2023, limb amputation is a common issue in orthopedic practice, with nearly 2 million individuals in the US living with limb loss as of 2005. Lower extremity amputations are also common, with 110,000 individual subject to major amputations annually. 70.0% of these are owing to disease, while the remaining are due to trauma, congenital abnormality, or tumor. Only 5.0% of amputees use their prosthesis for more than half of their daily walking.
The major companies serving the lower extremity devices market includes BREG, Inc., DARCO International, Inc, Drewshoe, Inc., Enovis, Essity AB., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market.
For instance, in February 2022, DePuySynthes acquired CrossRoads Extremity Systems, a Tennessee-based foot and ankle company that provides a broad range of procedure-specific, sterile-packed implants and instrumentation systems cleared for lower extremity indications. HealthpointCapital, a private equity firm, invested in CrossRoads, a foot and ankle growth leader, demonstrating DePuySynthes' commitment to orthopedic, podiatric, and MedTech advancements through internal and external innovation.